PHASE-II TRIAL OF 1,2-DIAMINOCYCLOHEXANE-(4-CARBOXYPHTHALATO) PLATINUM(II) IN PATIENTS WITH REFRACTORY GERM-CELL TUMORS

被引：0
|
作者：
CHUN, H [1 ]
BOSL, GJ [1 ]
GOLBEY, RB [1 ]
机构：
[1] CORNELL UNIV,MED CTR,COLL MED,DEPT MED,NEW YORK,NY 10021
来源：
CANCER TREATMENT REPORTS | 1985年 / 69卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：459 / 460
页数：2
相关论文
共 50 条
  • [31] PHASE-II TRIAL OF CARBOPLATIN IN PATIENTS WITH ADVANCED GERM-CELL TESTICULAR-TUMORS AND TRANSITIONAL CELL CARCINOMAS OF THE URINARY-TRACT
    AKAZA, H
    HAGIWARA, M
    DEGUCHI, N
    KAWAI, T
    SATOMI, Y
    MATSUDA, T
    MIKI, T
    UEDA, T
    KOTAKE, T
    TAZAKI, H
    ASO, Y
    NIIJIMA, T
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 23 (03) : 181 - 185
  • [32] 5-AZACYTIDINE (NSC-102816) IN REFRACTORY GERM-CELL TUMORS - A PHASE-II TRIAL OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP
    ROTH, BJ
    ELSON, P
    SLEDGE, GW
    EINHORN, LH
    TRUMP, DL
    INVESTIGATIONAL NEW DRUGS, 1993, 11 (2-3) : 201 - 202
  • [33] Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors
    Ashkar, Ryan
    Feldman, Darren R.
    Adra, Nabil
    Zaid, Mohammad Abu
    Funt, Samuel A.
    Althouse, Sandra K.
    Perkins, Susan M.
    Snow, Christin I.
    Lazzara, Kayla M.
    Sego, Lina M.
    Quinn, David I.
    Hanna, Nasser H.
    Einhorn, Lawrence H.
    Albany, Costantine
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (06) : 1656 - 1663
  • [34] Phase II Clinical Trial of Oxaliplatin and Bevacizumab in Refractory Germ Cell Tumors
    Jain, Amit
    Brames, Mary J.
    Vaughn, David J.
    Einhorn, Lawrence H.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (05): : 450 - 453
  • [35] Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors
    Ryan Ashkar
    Darren R. Feldman
    Nabil Adra
    Mohammad Abu Zaid
    Samuel A. Funt
    Sandra K. Althouse
    Susan M. Perkins
    Christin I. Snow
    Kayla M. Lazzara
    Lina M. Sego
    David I. Quinn
    Nasser H. Hanna
    Lawrence H. Einhorn
    Costantine Albany
    Investigational New Drugs, 2021, 39 : 1656 - 1663
  • [36] Phase II trial of bevacizumab (BEV)/high-dose chemotherapy (HDC) for refractory germ-cell tumors (GCT).
    Nieto, Yago
    Tannir, Nizar M.
    Tu, Shi-Ming
    Jones, Roy B.
    Zurita, Amado J.
    Aparicio, Ana
    Bassett, Roland
    Margolin, Kim Allyson
    Holmberg, Leona
    Champlin, Richard E.
    Pagliaro, Lance C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [37] HIGH-DOSE EPIRUBICIN IN CHEMOTHERAPY REFRACTORY NONSEMINOMATOUS GERM-CELL CANCER - A PHASE-II STUDY
    STOTER, G
    AKDAS, A
    FOSSA, SD
    KAYE, SB
    VANGROENINGEN, CJ
    RENARD, J
    VANGLABBEKE, M
    ANNALS OF ONCOLOGY, 1992, 3 (07) : 577 - 578
  • [38] ALL-TRANS-RETINOIC ACID FOR TREATING GERM-CELL TUMORS - IN-VITRO ACTIVITY AND RESULTS OF A PHASE-II TRIAL
    MOASSER, MM
    MOTZER, RJ
    KHOO, KS
    LYN, P
    MURPHY, BA
    BOSL, GJ
    DMITROVSKY, E
    CANCER, 1995, 76 (04) : 680 - 686
  • [39] PHASE-II STUDY OF IPROPLATIN (CHIP) IN PATIENTS WITH CISPLATIN-REFRACTORY GERM-CELL TUMORS - THE NEED FOR ALTERNATIVE STRATEGIES IN THE INVESTIGATION OF NEW AGENTS IN GCT
    MURPHY, BA
    MOTZER, RJ
    BOSL, GJ
    INVESTIGATIONAL NEW DRUGS, 1992, 10 (04) : 327 - 330
  • [40] PHASE-I/II TRIAL OF ULTRAHIGH CARBOPLATIN, ETOPOSIDE CYCLOPHOSPHAMIDE WITH ABMT IN REFRACTORY OR RELAPSED NONSEMINOMATOUS GERM-CELL TUMORS
    LINKESCH, W
    KRAINER, M
    WAGNER, A
    BONE MARROW TRANSPLANTATION, 1992, 10 : 28 - 29
12345